Importantly, as it is well established that human tumours frequently mutate or alter the expression of their STING pathway, it would be informative to understand if the newer, more diverse set of CONs positively impact tumour immune surveillance through STING or other CON receptors like RECON. Here, STING1 is linked to neoplasm.